Research Frontiers (REFR) Common Equity (2010 - 2026)

Research Frontiers has disclosed Common Equity across 17 years of filings, most recently posting $1.8 million for Q1 2026.

• Common Equity for Q1 2026 came in at $1.8 million, down 25.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 25.82% YoY), and the FY2025 annual result was $933626.0, down 64.15% from the prior year.
• Common Equity came in at $1.8 million for Q1 2026 at Research Frontiers, up from $933626.0 in the prior quarter.
• In the past five years, Common Equity ranged from a high of $5.4 million in Q3 2022 to a low of $933626.0 in Q4 2025.
• The 5-year median for Common Equity is $3.0 million (2024), against an average of $3.1 million.
• Across the five-year window, Common Equity surged 79.19% in 2023 and slumped 64.15% in 2025, its largest moves.
• Research Frontiers' Common Equity stood at $4.8 million in 2022, then slipped by 26.67% to $3.5 million in 2023, then declined by 25.97% to $2.6 million in 2024, then plunged by 64.15% to $933626.0 in 2025, then jumped by 92.8% to $1.8 million in 2026.
• The last three Common Equity figures came in at $1.8 million (Q1 2026), $933626.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.